UMRX - Unum Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-05-09)
Last
 4.81		 Change
 ⇓ -0.17   (-3.41%)		 Volume
  708,343
Open
 4.98		 High
 5.14		 Low
 4.81
8EMA (Daily)
 4.99		 40EMA (Daily)
 5.49		 50EMA (Daily)
 5.75		 STO (Daily)
 45.232		 MACD Hist (Daily)
 0.125
8EMA (Weekly)
 5.442		 40EMA (Weekly)
 7.55		 50EMA (Weekly)
 7.79		 STO (Weekly)
 16.761		 MACD Hist (Weekly)
 -0.391
Company Profile
Unum Therapeutics Inc is an US based clinical-stage biopharmaceutical company. it is focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com